Acutaas Chemicals P/B Ratio

Current P/B Ratio
17.09
High Valuation
Very High - Significant premium, high growth expectations or speculative

Acutaas Chemicals (ACUTAAS) P/B ratio is 17.09 (High), book value per share ₹417.32 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Read Acutaas Chemicals dividend payments for the complete payout history and dividend yield track record.

Current Valuation Metrics

P/B Ratio 17.09
Current Price ₹3440.30
Book Value/Share ₹417.32
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹1,711 Cr
Share Capital ₹41 Cr
Reserves & Surplus ₹1,613 Cr
Outstanding Shares 41,000,000
Book Value per Share ₹417.32

Valuation Signal

Signal Overvalued
Historical Avg 5.22
Historical Range 3.33 - 8.24
Percentile 100.0%

Sector Context

Sector Average -0.01
Sector Median 0.62
Sector Rank #11 of 50
Sector Percentile 22.0%

ACUTAAS P/B Ratio — Valuation Insights & Book Value Analysis

Acutaas Chemicals price-to-book ratio interpretation, valuation status and historical context — current P/B 17.09 (High). Explore ACUTAAS fundamental worth to estimate fundamental worth using multiple valuation models.

  • Stock appears overvalued with PB of 17.09, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 227.5% above historical average
  • Trading at premium to sector average PB of -0.01

Acutaas Chemicals P/B Ratio Historical Trend

ACUTAAS annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Acutaas Chemicals share price today.

ACUTAAS Historical P/B Ratio — Book Value Per Share & Year-End Price

Acutaas Chemicals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 8.24 ₹417.32 ₹3440.30 ₹1,711 High
2025 5.3 ₹321.95 ₹1704.90 ₹1,320 High
2024 5.82 ₹184.59 ₹1074.40 ₹683 High
2023 3.4 ₹165.0 ₹561.00 ₹594 High
2022 3.33 ₹145.0 ₹482.70 ₹522 High

ACUTAAS vs Healthcare Peers — P/B Ratio Comparison

Acutaas Chemicals P/B 17.09 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.

Sector Average
-0.01
Sector Median
0.62
Lowest P/B
-6.55
Highest P/B
1.09
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.0 ₹65 Low
Krebs Biochemicals & Ind… KREBSBIO -0.82 ₹129 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.21 ₹50 Low
Triochem Products TRIPR 0.04 ₹0 Low